Pomiferin was identified and named in 1939 by Melville L. Wolfrom from Ohio State University.[2] In 1941, Wolfram classified pomiferin as an isoflavone and in 1946 published the complete structure of pomiferin.[3] In 2003, the crystal structure of pomiferin was reported by J. Marek.[4]
In recent research pomiferin has demonstrated efficacy as an antioxidant, cardioprotectant, antimicrobial, antidiabetic, PDE5 inhibitor, and cytotoxicity for several cancer cell lines.
Research
Repellent
Peterson and Fristad (2000) investigated folklore beliefs stating that osage orange fruit repelled insects. They concluded that pure pomiferin had little or no effect and that there must be another component of the Osage orange that repels insects.[5]
Necas and Bartosíková (2007) reported that the chemical had potent cardioprotective effect on rat hearts subjected to ischemia and reperfusion injury. The mechanism for this protection may occur through the inhibition of lipid peroxidation.[8]
Bartosíková and Necas (2007), furthermore, conducted a biochemical examination showing antioxidative and antidiabetic effects of pomiferin.[10]
Moon (2014) presented results of a study that evaluated the antidiabetic effect of osajin and pomiferin from the Osage orange in normal and streptozotocin-induced diabetic rats. Pomiferin in the streptozotocin-induced diabetic rats resulted in significant hypoglycemic activity for 14 days following, by decreased the serum glucose and triglycerides while increasing seruminsulin in those rats.[11]
^Orhan, I (2009). "Cholinesterase inhibitory effects of the extracts and compounds of Maclura pomifera (Rafin.) Schneider". Food and Chemical Toxicology. 47 (8): 1747–51. doi:10.1016/j.fct.2009.04.023. PMID19394400.
^Bartosíková, L (2007). "Examination of the antioxidative and antidiabetic effect of pomiferin in alloxan-induced diabetes mellitus in". Ceska Slov Farm. 56 (3): 135–40. PMID17867526.
^Moon, H. I. (2014). "Effect of osajin and pomiferin on antidiabetic effects from normal and streptozotocin-induced diabetic rats". Nat Prod Commun. 9 (12): 1723–4. PMID25632468.
^Ribaudo, G. (2015). "Semi-synthetic derivatives of natural isoflavones from Maclura pomifera as a novel class of PDE-5A inhibitors". Fitoterapia. 105: 132–138. doi:10.1016/j.fitote.2015.06.020. PMID26136059.
^Svasti, J. (2005). "Proteomic profiling of cholangiocarcinoma cell line treated with pomiferin from Derris malaccensis". Proteomics. 5 (17): 4504–9. doi:10.1002/pmic.200401315. PMID16220529. S2CID38899441.
Son, Il Hong; et al. (2007). "Pomiferin, histone deacetylase inhibitor isolated from the fruits of Maclura pomifera". Bioorganic & Medicinal Chemistry Letters. 17 (17): 4753–4755. doi:10.1016/j.bmcl.2007.06.060. PMID17662606.
Svasti, Jisnuson; et al. (2005). "Proteomic profiling of cholangiocarcinoma cell line treated with pomiferin from Derris malaccensis". Proteomics. 5 (17): 4504–4509. doi:10.1002/pmic.200401315. PMID16220529. S2CID38899441.